|
|
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, N.C., with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Hatteras was founded in 2000 by John Crumpler and Clay Thorp with the launch of its first venture capital fund, Hatteras Venture Partners I, a pre-seed fund that has generated top decile returns focused predominantly on company formation in the life sciences. In 2004, the firm raised its second fund, Hatteras Venture Partners II, a later-stage fund invested through a partnership with HBM BioCapital. Currently, with five funds, the firm has more than $450 million under management. The first fund, HVP I, is a $3 million fund focused on pre-seed and company formation. The second fund, HVP II, is a $35 million investment in HBM BioCapital, through which Hatteras is an investment advisor. HVP III is an $83 million early-stage fund that invests in breakthrough discoveries that impact human medicine, and HVP IV, a fund launched with $74 million and reached its target size of $125 million on January 7, 2013, is also known as Hatteras Discovery, and is focused on seed-stage companies and projects in the field of human medicine and life sciences. The firm seeks to invest between $500,000 and $4 million initially and $5 to $10 million total in companies located in the U.S., with a preference for the Southeast and Mid-Atlantic.
|
